ALLERJECT is a portable epinephrine auto-injector with an innovative voice instruction system that helps guide patients and caregivers step-by-step through the injection process and has a retractable ...

VANCOUVER, Jan. 21, 2013 /CNW/ - Sanofi Canada announces a new option for the emergency treatment of anaphylaxis. Allerject™ is the first and only 'talking' epinephrine auto-injector in Canada.

Richmond-based pharmaceutical company Kaléo announced Wednesday it is expanding its market to Canada, offering its epinephrine auto-injector Allerject. The product used to treat severe allergic ...

Sanofi ( SNY) recently announced that its epinephrine injection, Allerject, is available in Canada for the emergency treatment of anaphylactic reactions in patients at risk or with a history of ...

Proactive financial news and online broadcast teams provide fast, accessible, informative and actionable business and finance news content to a global investment audience. All our content is produced ...

French pharmaceutical giant Sanofi-Aventis (S.A.) is recalling their Auvi-Q and Allerject auto-injectors in the United States (U.S.) and Canada, respectively for potentially inaccurate doses. Used for ...

Allerject, out to dethrone market leader EpiPen, knew it had a better auto-injector. It’s easier to carry and use, which helped it aim at the EpiPen’s weakness — it’s so bulky and cumbersome people ...